
Profusa Surges 135% on PanOmics Acquisition Push Into Booming Diagnostics Market
Profusa acquires BioInsights' PanOmics platform in all-equity deal, gaining $30M equity boost and expanding into multi-billion precision diagnostics market. Stock surges 135% on strategic expansion.
PFSAacquisitioncommercialization